These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 8137474)
21. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis]. Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446 [TBL] [Abstract][Full Text] [Related]
22. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma]. Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754 [TBL] [Abstract][Full Text] [Related]
23. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors. Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587 [TBL] [Abstract][Full Text] [Related]
24. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension]. Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891 [TBL] [Abstract][Full Text] [Related]
25. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671 [TBL] [Abstract][Full Text] [Related]
26. Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. Kanematsu M J Gastroenterol; 1995 Apr; 30(2):215-23. PubMed ID: 7773353 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823 [TBL] [Abstract][Full Text] [Related]
28. [Therapeutic effects by implantable infusion pump for hepatic malignant tumors]. Aoki Y; Hirai K; Ono N; Hiratuka H; Sakata K; Noguchi H; Yamashita K; Sakai T; Majima Y; Tanikawa K Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1748-53. PubMed ID: 2167648 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma. Nakamura K; Takashima S; Takada K; Fujimoto K; Kaminou T; Nakatsuka H; Minakuchi K; Onoyama Y Cancer Chemother Pharmacol; 1992; 31 Suppl():S93-8. PubMed ID: 1333916 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Yoshikawa M; Saisho H; Ebara M; Iijima T; Iwama S; Endo F; Kimura M; Shimamura Y; Suzuki Y; Nakano T Cancer Chemother Pharmacol; 1994; 33 Suppl():S149-52. PubMed ID: 8137478 [TBL] [Abstract][Full Text] [Related]
31. [Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)]. Onohara S; Ogita M; Shimada J; Hiraki Y; Abeyama K; Nakajo M Gan To Kagaku Ryoho; 1992 Mar; 19(3):315-21. PubMed ID: 1311912 [TBL] [Abstract][Full Text] [Related]
32. [Intra-arterial infusion chemotherapy for hepatocellular carcinoma using an implantable drug delivery system]. Sakata K; Hirai K; Izyuin H; Kajiwara M; Itano S; Ono N; Noguchi H; Aoki Y; Tanikawa K Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1478-80. PubMed ID: 1326912 [TBL] [Abstract][Full Text] [Related]
33. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M; AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167 [TBL] [Abstract][Full Text] [Related]
35. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. Itamoto T; Nakahara H; Tashiro H; Haruta N; Asahara T; Naito A; Ito K J Surg Oncol; 2002 Jul; 80(3):143-8. PubMed ID: 12115797 [TBL] [Abstract][Full Text] [Related]
36. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma]. Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684 [TBL] [Abstract][Full Text] [Related]
37. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993 [TBL] [Abstract][Full Text] [Related]
38. [Efficacy of intra-arterial chemotherapy with reservoir for patients with unresectable hepatocellular carcinoma]. Yasuhara M; Une Y; Shimamura T; Misawa K; Masuko Y Gan To Kagaku Ryoho; 1996 Mar; 23(4):455-8. PubMed ID: 8678497 [TBL] [Abstract][Full Text] [Related]
39. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up]. Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569 [TBL] [Abstract][Full Text] [Related]
40. [Prophylactic chemotherapy by regional arterial infusion in resected hepatoma patients]. Nakashima K; Kim YI; Okada K; Iwao Y; Aramaki M; Kobayashi M; Aikawa H; Suzuki K Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1489-92. PubMed ID: 1326914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]